Skip to main content
. 2021 Dec 22;13(1):276–286. doi: 10.1002/jcsm.12895

Table 2.

Results of the physical examination and laboratory tests

Variable Elders without sarcopenia (n = 24) Elders with sarcopenia (n = 24) Young adults (n = 24) P value a (two groups) P value b (three groups)
Median (Q1, Q3) Median (Q1, Q3) Median (Q1, Q3)
Physical examination
Height (cm) 155.1 (149.5, 161.8) 155.2 (150.8, 163.6) 165.6 (162.8, 175.3) 0.6467 <0.0001
Weight (kg) 64.1 (58.1, 69.7) 50.7 (46.4, 55.2) 62.3 (54.1, 75.5) <0.0001 <0.0001
Body mass index (kg/m2) 26.3 (25.1, 27.0) 21.2 (19.7, 22.0) 22.5 (20.9, 25.4) <0.0001 <0.0001
ASMI (kg/m2) 6.5 (5.8, 7.7) 5.3 (5.1, 6.3) NA <0.0001 d
Fat mass percentage (%) 37.7 (30.7, 43.1) 31.7 (22.3, 35.9) NA 0.0080
Waist circumstance (cm) 94.5 (88.0, 98.5) 82.0 (77.8, 85.5) 79.0 (70.8, 87.0) <0.0001 <0.0001
Muscle strength (kg) 21.0 (16.0, 31.0) 15.0 (12.0, 21.5) NA 0.0231
Gait speed (m/s) 0.9 (0.6, 1.3) 0.7 (0.5, 0.9) NA 0.0461
Blood pressure
Systolic (mmHg) 129.0 (119.0, 139.0) 130.0 (119.5, 138.5) 112.0 (108.5, 121.5) 0.9433 0.0005
Diastolic (mmHg) 70.0 (69.0, 76.0) 71.5 (69.5, 80.0) 78.0 (67.5, 83.5) 0.2880 d 0.2010 e
Laboratory tests
RBC (M/μL) 4.4 (3.8, 4.5) 4.3 (4.1, 4.5) 4.8 (4.4, 5.3) 0.5983 0.0004 e
Haemoglobin (g/dL) 12.7 (11.3, 13.3) 13.0 (12.4, 13.7) 13.9 (13.1, 15.4) 0.3217 0.0014 e
Platelet (K/μL) 240.5 (189.5, 272.5) 223.0 (185.0, 265.0) 259.5 (227.5, 289.5) 0.7571 d 0.0989 e
WBC (K/μL) 6.2 (5.5, 7.2) 6.5 (5.5, 7.0) 6.5 (6.1, 7.8) 0.8874 0.2924
Neutrophil (%) 57.0 (53.5, 62.4) 60.5 (49.9, 66.3) 59.1 (56.1, 63.2) 0.6678 0.7083
Lymphocyte (%) 33.6 (28.7, 35.7) 30.5 (25.6, 42.8) 32.0 (30.0, 35.2) 0.8778 0.8619
Albumin (g/dL) 4.5 (4.4, 4.0) 4.6 (4.4, 4.8) 4.9 (4.9, 5.1) 0.5829 0.0003
Glucose AC (mmol/L) 5.7 (5.2, 7.4) 5.8 (4.9, 7.4) 4.6 (4.3, 4.9) 0.7334 d <0.0001 e
Total cholesterol (mmol/L) 5.0 (4.4, 5.8) 4.6 (4.1, 5.2) 4.9 (4.5, 5.5) 0.2374 d 0.4305 e
Triglyceride (mmol/L) 1.7 (1.1, 2.4) 1.3 (0.8, 1.9) 0.9 (0.6, 1.2) 0.0370 d 0.0007 e
AST (μkat/L) 0.3 (0.3, 0.4) 0.4 (0.3, 0.9) 0.3 (0.3, 0.4) 0.1291 d 0.2931 e
ALT (μkat/L) 0.3 (0.2, 0.4) 0.3 (0.2, 0.4) 0.3 (0.2, 0.5) 0.4955 d 0.1559 e
BUN (mmol/L) 6.0 (4.8, 9.4) 6.8 (4.7, 8.3) 3.8 (3.2, 4.6) 0.9124 d <0.0001 e
Creatinine (μmol/L) 88.4 (84.0, 110.5) 97.2 (79.6, 123.8) 84.0 (70.7, 97.2) 0.9834 d 0.0802 e
MDRD‐simplify‐GFR c (mL/min/1.73 m2) 57.4 (46.2, 74.4) 59.3 (46.7, 71.4) 88.5 (83.3, 92.8) 0.9151 <0.0001
Uric acid (μmol/L) 362.9 (321.2, 386.7) 336.1 (276.6, 419.4) 315.3 (291.5, 386.7) 0.3967 d 0.6120 e
Log (TNF‐α (pg/mL)) 1.6 (1.5, 1.7) 1.6 (1.2, 1.8) NA 0.6567 d
Log (CRP (nmol/L)) 1.3 (1.2, 1.8) 1.3 (1.1, 1.5) NA 0.1801 d
Log (irisin (ng/mL)) 2.8 (2.5, 3.2) 3.1 (2.2, 3.3) 2.4 (2.0, 3.0) 0.2376 d 0.0427 e
Log (GDF‐15 (pg/mL)) 6.1 (5.7, 6.5) 6.2 (5.6, 6.6) 4.8 (4.6, 5.0) 0.5728 d <0.0001 e

ALT, alanine aminotransferase; ASMI, appendicular skeletal muscle index; AST, aspartate aminotransferase; BUN, blood urine nitrogen; CRP, C‐reactive protein; GDF‐15, growth differentiation factor 15; GFR, glomerular filtration rate; MDRD, Modification of Diet in Renal Disease; RBC, red blood cell; TNF‐α, tumour necrosis factor‐α; WBC, white blood cell.

a

Elders without sarcopenia vs. elders with sarcopenia.

b

Among elders without sarcopenia, elders with sarcopenia, and young adults.

c

MDRD‐simplify‐GFR (mL/min/1.73 m2) = 186 × [(CRE)−1.154] × [(age)−0.203] (if male); MDRD‐simplify‐GFR (mL/min/1.73 m2) = 186 × [(CRE)−1.154] × [(age)−0.203] × 0.742 (if female).

d

Wilcoxon–Mann–Whitney test.

e

Kruskal–Wallis test.